Latest Articles
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare
Published: Aug. 26, 2025, 8:55 a.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare World
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare World
Published: Aug. 26, 2025, 8:55 a.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - India Education Diary
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers India Education Diary
Published: Aug. 25, 2025, 3:28 p.m.
GSK forays into oncology in India bringing precision therapies for gynaecological cancers - BioSpectrum India
GSK forays into oncology in India bringing precision therapies for gynaecological cancers BioSpectrum India
Published: Aug. 25, 2025, 2:19 p.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - APN News
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers APN News
Published: Aug. 25, 2025, 11:04 a.m.
GSK enters into oncology segment; launches therapies for gynaecological cancers - newsdrum.in
GSK enters into oncology segment; launches therapies for gynaecological cancers newsdrum.in
Published: Aug. 25, 2025, 8 a.m.
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers - TipRanks
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers TipRanks
Published: Aug. 20, 2025, 4:06 p.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers - APN News
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers APN News
Published: Aug. 7, 2025, 5:45 a.m.
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post
Published: Aug. 6, 2025, 3:38 p.m.
Uterine Cancers Outpace Clinical Tools to Curb Them - Medscape
Uterine Cancers Outpace Clinical Tools to Curb Them Medscape
Published: Aug. 5, 2025, 12:02 p.m.
Link copied to clipboard!